Benzinga | Jul 27, 2021 11:13AM EDT

electroCore Announces Issuance Of US Patent For Migraine Treatment Using Smartphones

electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,065,444 to electroCore, relating to the use of a mobile phone for stimulating the trigeminal nerve to treat disorders.